DOI:
10.1055/s-00030576
Revista Brasileira de Ginecologia e Obstetrícia / RBGO Gynecology and Obstetrics
LinksClose Window
References
Phippen NT, Leath III CA, Havrilesky LJ, Barnett JC.
Bevacizumab in recurrent, persistent, or advanced stage carcinoma of the cervix: is it cost-effective?.
Gynecol Oncol 2015;
136 (01) 43-47 . Doi: 10.1016/j.ygyno.2014.11.003
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.